Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | +2.63% | +8.33% | -32.29% |
May. 13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 56.82M | Sales 2025 * | 80.37M | Capitalization | 78.05M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -4M | EV / Sales 2024 * | 1.37 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
-4.17
x | P/E ratio 2025 * |
-16.3
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.62% |
Latest transcript on Journey Medical Corporation
1 day | +2.63% | ||
1 week | +8.33% | ||
1 month | +11.11% | ||
3 months | -5.57% | ||
6 months | -11.36% | ||
Current year | -32.29% |
Managers | Title | Age | Since |
---|---|---|---|
Claude Maraoui
FOU | Founder | 57 | 14-09-30 |
Joseph Benesch
DFI | Director of Finance/CFO | 57 | 21-10-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 14-09-30 | |
Neil Herskowitz
BRD | Director/Board Member | 67 | 20-12-31 |
Miranda Toledano
BRD | Director/Board Member | 47 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.9 | +2.63% | 112,116 |
24-05-30 | 3.8 | -1.30% | 67,812 |
24-05-29 | 3.85 | +6.94% | 245,518 |
24-05-28 | 3.6 | -.--% | 157,332 |
24-05-24 | 3.6 | -.--% | 37,828 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.29% | 78.05M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- DERM Stock